MEM-488

N/A

Report date: 2025/01/26 17:29:20

Base Information

Drug NameMEM-488

Drug Alias Namedendritic cell therapy expressing MEM-40 (Memgen)dendritic cell therapy expressing CD40 costimulator and multi-payload (Memgen)multi-payload dendritic cell therapy (Memgen)MEM-488

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMemgen Llc

China Registration ClassN/A

Develop Information

Active CompaniesMemgen Llc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A